10.1002/ardp.201100072
The research aims to develop a new and safer drug for tuberculosis by synthesizing and evaluating a series of fluoronitrobenzothiazolopyrazolines for their antitubercular activity. The study focuses on three subclasses of compounds: fluorobenzothiazolopyrazolines, fluoronitrobenzothiazolopyrazolines with the nitro group at the 5th position, and those with the nitro group at the 4th position. The compounds were tested for their in-vitro antitubercular activity against the Mycobacterium tuberculosis H37Rv strain using Middlebrook 7H-9 broth. The results showed that the introduction of a nitro group at the 5th position of the benzothiazole ring significantly increased antitubercular activity, while the introduction at the 4th position decreased it. Electron-donating substituents in the aromatic ring also enhanced activity. Selected compounds were further tested for cytotoxicity on THP-1 cell lines, showing low cytotoxicity compared to their antitubercular activity. Key chemicals used in the synthesis include 4-fluoro-3-chloroaniline, potassium thiocyanate, hydrazine hydrate, acetic anhydride, nitric acid, sulfuric acid, and various aromatic aldehydes. The study concludes that fluoronitrobenzothiazolopyrazolines with specific substituents show promising antitubercular activity and could serve as potential candidates for further drug development.